Holding Pattern There are a number of ways to look at these low volumes. Imho while investors aren't buying neither are they selling. THRM isn't dead (there is nothing to suggest this), the company doesn't need HC or FDA as this will not be the essential market for AcuVid ( at least not immediately) and 2028 ....lol!
Red Tape abounds at every juncture and while there are many PCR tests that were approved by government agencies around the world there have been much fewer approvals for rapid tests and even less for rapid antigen, point of care tests. Even for those that have been approved cost, accuracy and sample type have led to limited use.
THRM has addressed all of these concerns as per their most recent NR. Outside of seeking approval in Brazil (which may have already taken place) they have now established a means of manufacturing millions of tests in Asia. Imho the only NR worth sharing now is (are) a major contract(s).
We know it works, there is a heavy weight marketing group behind it, there is a conditional contract (albeit small) and nothing so far precludes anything but a positive outcome for THRM and the shareholders. Having said that there is no crystal ball.
GLTE!!!